Cargando…
2-[(18)F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer
This study aimed to compare CE-CT and 2-[(18)F]FDG-PET/CT for response monitoring metastatic breast cancer (MBC). The primary objective was to predict progression-free and disease-specific survival for responders vs. non-responders on CE-CT and 2-[(18)F]FDG-PET/CT. The secondary objective was to ass...
Autores principales: | Vogsen, Marianne, Naghavi-Behzad, Mohammad, Harbo, Frederik Graae, Jakobsen, Nick Møldrup, Gerke, Oke, Asmussen, Jon Thor, Nissen, Henriette Juel, Dahlsgaard-Wallenius, Sara Elisabeth, Braad, Poul-Erik, Jensen, Jeanette Dupont, Ewertz, Marianne, Hildebrandt, Malene Grubbe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076261/ https://www.ncbi.nlm.nih.gov/pubmed/37019987 http://dx.doi.org/10.1038/s41598-023-32727-w |
Ejemplares similares
-
Comparison of Image Quality and Quantification Parameters between Q.Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023) -
The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [(18)F]FDG-PET/CT and CE-CT
por: Gram-Nielsen, Rosa, et al.
Publicado: (2023) -
Prognostic Value of Dual-Time-Point (18)F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2020) -
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2021) -
Cost-effectiveness of 2-[(18)F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2023)